Annual FCF
-$8.48 M
-$825.00 K-10.78%
December 1, 2023
Summary
- As of February 10, 2025, NRSN annual free cash flow is -$8.48 million, with the most recent change of -$825.00 thousand (-10.78%) on December 1, 2023.
- During the last 3 years, NRSN annual FCF has fallen by -$7.78 million (-1104.69%).
- NRSN annual FCF is now -1339.90% below its all-time high of -$589.00 thousand, reached on December 31, 2019.
Performance
NRSN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
N/A
September 1, 2024
Summary
- NRSN quarterly free cash flow is not available.
Performance
NRSN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
N/A
September 1, 2024
Summary
- NRSN TTM free cash flow is not available.
Performance
NRSN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
NRSN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.8% | - | - |
| 3 y3 years | -1104.7% | - | - |
| 5 y5 years | -1339.9% | - | - |
NRSN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -445.1% | at low | ||||
| 5 y | 5-year | -1339.9% | at low | ||||
| alltime | all time | -1339.9% | at low |
NeuroSense Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | -$5.75 M(+46.5%) | -$5.75 M(+46.5%) |
| Dec 2023 | -$8.48 M(+10.8%) | - | - |
| Jun 2023 | - | -$3.93 M(-9.0%) | -$3.93 M(-9.0%) |
| Dec 2022 | -$7.66 M(+392.0%) | - | - |
| Jun 2022 | - | -$4.32 M | -$4.32 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$1.56 M(+121.0%) | - | - |
| Jun 2021 | - | -$405.00 K(-100.0%) | $5.59 B(-0.0%) |
| Mar 2021 | - | $5.59 B | $5.59 B |
| Dec 2020 | -$704.00 K(+19.5%) | - | - |
| Dec 2019 | -$589.00 K | - | - |
FAQ
- What is NeuroSense Therapeutics annual free cash flow?
- What is the all time high annual FCF for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual FCF year-on-year change?
- What is the all time high quarterly FCF for NeuroSense Therapeutics?
- What is the all time high TTM FCF for NeuroSense Therapeutics?
What is NeuroSense Therapeutics annual free cash flow?
The current annual FCF of NRSN is -$8.48 M
What is the all time high annual FCF for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual free cash flow is -$589.00 K
What is NeuroSense Therapeutics annual FCF year-on-year change?
Over the past year, NRSN annual free cash flow has changed by -$825.00 K (-10.78%)
What is the all time high quarterly FCF for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly free cash flow is $5.59 B
What is the all time high TTM FCF for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high TTM free cash flow is $5.59 B